Hopefully the product / patent are being flogged around the world for a buyer. Yes QUT would have to consent to a sale but that shouldnt be a deal killer. I would imagine QUT would like to see the product come to market even under different ownership.
At the same time I hope the person acting as Chairman is seeking and finding new shareholders that could take part in a Sophisticated Investor raising. Hunter Hall would be a good one they have taken a stewardship role with a number biotechs from post listing to commercial success.
At the same time the ppl working on claiming the R&D grants for the past few years should be well advanced in getting funds back from the government that will increase the chance of getting to approval.
By this time the cull of non-essential costs should be nearly complete dramatically cutting running costs to maximise the chance of getting to approval.
Alternative funding methods for FDA approval and completion of CE Mark approval should also be on the table.
Or maybe they are just playing candy crush and getting their resumes ready.
TIS Price at posting:
3.8¢ Sentiment: Hold Disclosure: Held
